These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3227 related articles for article (PubMed ID: 26079897)

  • 1. Reply to: the "Reply to Slankamenac et al's Comprehensive Complication Index Validation Study (November 2014)".
    Slankamenac K; Puhan MA; Clavien PA
    Ann Surg; 2016 Aug; 264(2):e12. PubMed ID: 26079897
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to Slankamenac et al's Comprehensive Complication Index Validation Study.
    Boney O; Moonesinghe R; Grocott M
    Ann Surg; 2016 Aug; 264(2):e11. PubMed ID: 26079896
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to Sayeed et al's Reply to Reply.
    Carragee EJ; Andersson GBJ; Belcourt RM; Eskay-Auerbach M; Goertz M; Haldeman S; Hegmann KT; Lessenger JE; Mayer T; Mueller KL; Murphy DR; Tellin WG; Thiese MS; Travis R; Weiss MS; Harris JS
    J Occup Environ Med; 2022 Jun; 64(6):e391-e392. PubMed ID: 35761429
    [No Abstract]   [Full Text] [Related]  

  • 4. In Reply to "Comments on Results of Carroll et al's Study on Survival Benefits of Gross Total Resection".
    Carroll KT; Chen CC
    World Neurosurg; 2018 Aug; 116():479-480. PubMed ID: 30049033
    [No Abstract]   [Full Text] [Related]  

  • 5. Quality of life in patients with early, moderate and advanced glaucoma.
    Iester M; Zingirian M
    Eye (Lond); 2002 Jan; 16(1):44-9. PubMed ID: 11913887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re: Letter to the Editor: P. van Damme et al., Vaccine 34 (2016) 757-761, as a reply to Ryser et al's letter in Vaccine.
    Van Damme P; Stanley M
    Vaccine; 2016 Aug; 34(36):4272. PubMed ID: 27452650
    [No Abstract]   [Full Text] [Related]  

  • 7. Response to Morrell et al's reply.
    Miller AB
    Br J Cancer; 2017 Nov; 117(10):e8. PubMed ID: 28934758
    [No Abstract]   [Full Text] [Related]  

  • 8. Tharyan et al's reply.
    Tharyan P
    Indian J Psychiatry; 1995 Apr; 37(2):100. PubMed ID: 21743727
    [No Abstract]   [Full Text] [Related]  

  • 9. Reply to: "Light and Shade in Patrick Lewis et al's Paper on the First Photographs of Parkinson's Disease".
    Lewis PA; Plun-Favreau H; Rowley M; Spillane J
    Mov Disord; 2020 Oct; 35(10):1882. PubMed ID: 33068469
    [No Abstract]   [Full Text] [Related]  

  • 10. Reply to Vardan et al's "Importance of intraarterial blood pressure measurement in the evaluation of a new antihypertensive agent and the need to define hypertension also by this method".
    O'Brien E; O'Malley K
    Am J Hypertens; 1991 Jul; 4(7 Pt 1):642-3. PubMed ID: 1873022
    [No Abstract]   [Full Text] [Related]  

  • 11. Response to Sheehan
    Hammersley M
    J Med Ethics; 2018 Oct; 44(10):717-718. PubMed ID: 29374621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reply to "Predictors of Recurrence for T3a RCC: A Recurring Conundrum".
    Miyake M; Shimizu T; Hori S; Iida K; Nakai Y; Fujimoto K
    Diagnostics (Basel); 2020 Nov; 10(11):. PubMed ID: 33233478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comments on Results of Carroll et al's Study on Survival Benefits of Gross Total Resection.
    Roux A; Zanello M; Pallud J
    World Neurosurg; 2018 Aug; 116():478. PubMed ID: 30049032
    [No Abstract]   [Full Text] [Related]  

  • 14. Comment on Manchikanti et al's ACOEM guideline criticism.
    Brown LL; Escobar LA; Stein A
    Pain Physician; 2008; 11(5):700; author reply 705-6. PubMed ID: 18850037
    [No Abstract]   [Full Text] [Related]  

  • 15. Comments on Glauser et al's article.
    Haynes JL; Glauser SC
    Arch Environ Health; 1971 Mar; 22(3):409. PubMed ID: 5541497
    [No Abstract]   [Full Text] [Related]  

  • 16. In reference to Manchikanti et al's criticism of ACOEM guidelines.
    Hegmann KT; Talmage JB; Genovese E; Feinberg SD; Korevaar WC; Mueller KL
    Pain Physician; 2008; 11(4):567-8; author reply 568-9. PubMed ID: 18690286
    [No Abstract]   [Full Text] [Related]  

  • 17. Assumptions and consequences of treating providers in therapy studies as fixed versus random effects: reply to Crits-Christoph, Tu, and Gallop (2003) and Serlin, Wampold, and Levin (2003).
    Siemer M; Joormann J
    Psychol Methods; 2003 Dec; 8(4):535-44. PubMed ID: 14664688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The United States is not the World: Response to Zeller et al's Call for Discussion on Nicotine Regulation.
    West R
    Nicotine Tob Res; 2019 Feb; 21(3):344. PubMed ID: 30312456
    [No Abstract]   [Full Text] [Related]  

  • 19. Comments on Chan and Flemmen et al's conceptualization of class, status and cultural consumption.
    Karademir Hazır I
    Br J Sociol; 2019 Jun; 70(3):892-897. PubMed ID: 31190394
    [No Abstract]   [Full Text] [Related]  

  • 20. Cachexia in cancer: what is in the definition?
    Vanhoutte G; van de Wiel M; Wouters K; Sels M; Bartolomeeussen L; De Keersmaecker S; Verschueren C; De Vroey V; De Wilde A; Smits E; Cheung KJ; De Clerck L; Aerts P; Baert D; Vandoninck C; Kindt S; Schelfhaut S; Vankerkhoven M; Troch A; Ceulemans L; Vandenbergh H; Leys S; Rondou T; Dewitte E; Maes K; Pauwels P; De Winter B; Van Gaal L; Ysebaert D; Peeters M
    BMJ Open Gastroenterol; 2016; 3(1):e000097. PubMed ID: 27843571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 162.